Oxbow Advisors LLC Sells 19,079 Shares of Nutrien Ltd. $NTR

Key Points

• Oxbow Advisors LLC has decreased its stake in Nutrien Ltd. by 15.4%, selling 19,079 shares during the second quarter, leaving it with a total of 104,954 shares valued at approximately $6.11 million.
• Nutrien reported $2.65 earnings per share for the latest quarter, surpassing analysts' expectations, though its revenue of $10.30 billion was slightly below estimates.
• The company announced a quarterly dividend of $0.545 per share, reflecting an annualized dividend yield of 3.9%, with the payment scheduled for October 17th.

Oxbow Advisors LLC lowered its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 15.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 104,954 shares of the company's stock after selling 19,079 shares during the quarter. Oxbow Advisors LLC's holdings in Nutrien were worth $6,113,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of NTR. JPMorgan Chase & Co. lifted its stake in Nutrien by 48.7% in the first quarter. JPMorgan Chase & Co. now owns 6,992,535 shares of the company's stock worth $347,319,000 after acquiring an additional 2,291,518 shares during the period. Vanguard Group Inc. lifted its position in shares of Nutrien by 7.1% in the 1st quarter. Vanguard Group Inc. now owns 21,191,003 shares of the company's stock worth $1,051,709,000 after purchasing an additional 1,412,503 shares during the period. Canada Pension Plan Investment Board boosted its stake in shares of Nutrien by 17.1% during the first quarter. Canada Pension Plan Investment Board now owns 8,786,309 shares of the company's stock valued at $436,137,000 after purchasing an additional 1,284,181 shares in the last quarter. Nuveen LLC purchased a new position in Nutrien during the first quarter valued at approximately $63,542,000. Finally, The Manufacturers Life Insurance Company raised its stake in Nutrien by 16.5% in the first quarter. The Manufacturers Life Insurance Company now owns 6,554,638 shares of the company's stock worth $326,927,000 after buying an additional 927,041 shares in the last quarter. 63.10% of the stock is owned by institutional investors.

Nutrien Price Performance

Nutrien stock opened at $56.41 on Friday. Nutrien Ltd. has a 52-week low of $43.69 and a 52-week high of $65.08. The firm has a market capitalization of $27.37 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 0.95 and a beta of 0.82. The company has a fifty day simple moving average of $57.74 and a 200-day simple moving average of $57.47. The company has a quick ratio of 0.85, a current ratio of 1.33 and a debt-to-equity ratio of 0.39.

Nutrien (NYSE:NTR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.41 by $0.24. Nutrien had a net margin of 5.25% and a return on equity of 6.51%. The business had revenue of $10.30 billion during the quarter, compared to analyst estimates of $10.40 billion. During the same quarter in the prior year, the firm earned $2.34 earnings per share. The company's revenue for the quarter was up 2.8% compared to the same quarter last year. On average, equities analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Monday, September 29th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 3.9%. The ex-dividend date of this dividend is Monday, September 29th. Nutrien's dividend payout ratio (DPR) is 78.14%.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Bank of America reiterated a "neutral" rating and set a $67.00 price objective on shares of Nutrien in a research note on Tuesday. Morgan Stanley lifted their price objective on shares of Nutrien from $60.00 to $65.00 and gave the company an "equal weight" rating in a research note on Thursday, June 26th. Wells Fargo & Company restated a "cautious" rating on shares of Nutrien in a research note on Thursday. UBS Group decreased their target price on shares of Nutrien from $64.00 to $63.00 and set a "neutral" rating for the company in a research note on Thursday, August 7th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Nutrien in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $62.78.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.